A ‘tailor made’ vaccine trialled as part of public health response to group B meningococcal epidemic in New Zealand

Articles Open Access

Like 0

This item has no PDF Download

J Holst, I S Aaberge, Philipp Oster, D Lennon, D Martin, J O'Hallahan, K Nord, H Nøkleby, L M Næss, L M Næss, P Kristiansen, A G Skryten, K Bryn, A Aase, R Rappuoli, E Rosenqvist
View Citation Hide Citation

Citation style for this article: Holst J, Aaberge I, Oster Philipp, Lennon D, D Martin, J O'Hallahan, K Nord, H Nøkleby, L M Næss, L M Næss, P Kristiansen, A G Skryten, K Bryn, A Aase, R Rappuoli, E Rosenqvist. A ‘tailor made’ vaccine trialled as part of public health response to group B meningococcal epidemic in New Zealand. Euro Surveill. 2003;7(30):pii=2262. https://doi.org/10.2807/esw.07.30.02262-en

New Zealand has experienced an epidemic of serogroup B meningococcal infection since 1991

Article metrics loading...

/content/10.2807/esw.07.30.02262-en

2003-07-24

2019-03-19

http://instance.metastore.ingenta.com/content/10.2807/esw.07.30.02262-en

Full text loading...

/deliver/fulltext/eurosurvweeklyarchive/7/30/art02262-en.htm?itemId=/content/10.2807/esw.07.30.02262-en&mimeType=html&fmt=ahah

Comment has been disabled for this content

Submit comment

Comment moderation successfully completed